Psoriasis Uncovered Podcast By National Psoriasis Foundation cover art

Psoriasis Uncovered

Psoriasis Uncovered

By: National Psoriasis Foundation
Listen for free

National Psoriasis Foundation presents "Psoriasis Uncovered" (formerly Psound Bytes™), a podcast series about psoriasis and psoriatic arthritis featuring leading experts who discuss topics that offer a better understanding of the disease and management, to coping and thriving with the disease. Listen to world renowned dermatologists and rheumatologists discuss the latest news in psoriatic disease management.Copyright © 2020 National Psoriasis Foundation/USA. Any duplication, rebroadcast, or other use of content from Psound Bytes podcasts is prohibited without written permission from the National Psoriasis Foundation. Hygiene & Healthy Living Physical Illness & Disease
Episodes
  • Ep. 273 "Moderate to Severe Plaque Psoriasis in Children and in Adults with High-Impact Site Involvement"

    Ep. 273 "Moderate to Severe Plaque Psoriasis in Children and in Adults with High-Impact Site Involvement"
    Apr 2 2026
    Description: Learn why advocating for care is crucial when moderate to severe plaque psoriasis develops at a young age or in high-impact sites, and how advanced biologic therapies can offer effective solutions for those that may be undertreated. Join moderator Kaitlin Walden, patient advocate Carolyn, and dermatologist Dr Candrice Heath as they discuss the realities of living with moderate to severe plaque psoriasis at a young age, as well as adult patients with plaque psoriasis in high-impact sites, like the scalp, nails, and face. Carolyn shares her personal journey with moderate to severe plaque psoriasis and how it has continued from childhood into adulthood, while Dr Heath offers insights to help caregivers and patients navigate treatment approaches, including when and how a biologic therapy may be helpful. This episode addresses challenges associated with living and treating moderate to severe plaque psoriasis in children and adults. This episode is sponsored by Johnson & Johnson. Please see Important Safety Information and full Prescribing Information for the product mentioned in this episode. Timestamps: · (0:23) Intro to Psoriasis Uncovered and guest introductions from dermatologist Dr. Candrice Heath and Carolyn, a patient advocate living with plaque psoriasis and psoriatic arthritis. · (1:22) Information about, and pivotal data for, TREMFYA® (guselkumab), a biologic used to treat adults and children 6 years and older who weigh at least 88 lbs or 40 kilograms with moderate to severe plaque psoriasis. · (3:48) Living with psoriasis as a child can be difficult with challenges in being diagnosed correctly and receiving appropriate treatment. · (6:17) A dermatologist's view of children and adolescents living with plaque psoriasis including in high-impact sites. · (8:14) It's important to advocate for yourself and the best possible care. · (9:37) Open communication with your dermatologist helps identify the best possible treatment plan, which is dependent on several factors including the availability of new treatment options. · (12:05) Carolyn's biggest challenge is managing her psoriasis and then psoriatic arthritis. · (14:20) Results of the SPECTREM clinical trial addressing treatment of adults with moderate plaque psoriasis in high-impact sites. · (17:38) Find the support and information you need to find the right treatment. · (21:48) Important Safety Information about TREMFYA® (guselkumab). Key Takeaways: · Plaque psoriasis can be challenging both physically and emotionally for children and adults – especially when high-impact site involvement (such as the face, scalp, armpits, and groin) is present. · Individual treatment plans vary and are based on several factors, including the severity of psoriasis, dosing schedule, cost, or route of administration. Finding the right treatment for plaque psoriasis is a collaboration between a dermatologist, the patient, and/or family (should the patient be a child). · A number of medicines that treat plaque psoriasis from the inside out, including biologics, are now available for children and adults. Such treatment options are continuing to expand. Guest Bios: Candrice Heath, M.D. is a highly respected triple board-certified dermatologist who sees both children and adults at Howard University Hospital in Washington DC where she is also an Associate Professor in the Department of Dermatology. She is board-certified in dermatology, pediatrics, and pediatric dermatology. Dr Heath is a nationally recognized speaker, pediatric and adult dermatology clinical researcher, and has held a variety of leadership roles including Chair for the Pediatric Dermatology Research Alliance (PeDRA), Skin of Color and Pigmentary Disorders Focused Group, Skin of Color Society National Secretary-Treasurer, and American Academy of Dermatology Diversity Committee member. Her clinical, research, and teaching interests are shaped by insights gained from her unique practice filled with both children and adults in addition to her passion for exploring the intersection of dermatology and social science. Carolyn Pugh is a patient advocate and volunteer with the National Psoriasis Foundation who lives with psoriasis and psoriatic arthritis. Carolyn was diagnosed with psoriasis at age 11 after being misdiagnosed and offered treatments that didn't work. Once she was diagnosed with plaque psoriasis some of the initial treatments were difficult and unsustainable. Over the years she has learned to advocate for her own self-care and feels her personal experiences can help empower other adults and parents. Resources: · Learn more about treatment options for children and adolescents at Our Spot for Youth and Parents · For more information about psoriasis in ...
    Show more Show less
    29 mins
  • Ep. 272 "Insights on the Use of Biosimilars for Psoriatic Disease"

    Ep. 272 "Insights on the Use of Biosimilars for Psoriatic Disease"
    Mar 12 2026
    Hear leading dermatologist Dr. E. James Song and patient advocate Ana Rinck share their perspectives on the use of biosimilars to manage psoriasis and psoriatic arthritis. The use of biosimilars is growing with 24 currently on the market and more on the way for the treatment of psoriasis and psoriatic arthritis. What does this mean for you? Find out as we explore the use of biosimilars, the impact of interchangeability, what it's like switching to a biosimilar, and what questions to ask your health care provider with leading dermatologist and NPF Medical Board member Dr. E. James Song, Director of Clinical Research at Frontier Dermatology Partners, and patient advocate Ana Rinck who currently uses a biosimilar to treat her psoriasis and psoriatic arthritis. The intent of this episode is to offer an update on the use of biosimilars and to hear the experience of those who have used biosimilars to manage psoriatic disease. This episode is sponsored by Organon. Timestamps: (0:00) Intro to Psoriasis Uncovered and guest welcome to dermatologist Dr. E. James Song, Director of Clinical Research and Co-Chief Medical Officer, Frontier Dermatology, and patient advocate Ana Rinck, who presents her experience with using a biosimilar to treat psoriasis and psoriatic arthritis. (0:58) Definition of what is a biosimilar in comparison to a biologic which is also referred to as the original bio-originator or reference product. (3:10) What biosimilars are available and how they are used. (4:35) The term interchangeable and what it means for use of a biosimilar. (5:46) Ana's diagnosis to treatment options starting with use of topicals to ultimately use of a biosimilar. (7:57) Treatment discussion and choices when faced with diminishing effectiveness within a class of medications. Should a biosimilar be considered as an option? (9:50) Questions to consider when there's a change in treatment. (10:57) FDA announcement to simplify the development process for biosimilars and what that means for the future use of biosimilars. (13:55) What to consider when thinking of a biosimilar as a treatment option and where to find help when needed. (14:53) The hope and equity of access that biosimilars represent is here for the appropriate individual. Key Takeaways: · A biosimilar is an FDA-approved biologic product that behaves and functions like a brand biologic treatment which is also called the reference product or bio-originator. There are no clinically meaningful differences between biosimilars and their reference product. · The FDA has approved several biosimilars for the treatment of psoriasis and psoriatic arthritis. Some have been identified as interchangeable which means a biosimilar could be substituted for a reference product without a health care provider's approval pending state legislative rules. · Don't be afraid to ask questions or access resources to assist with preparing for a medication change should that change be initiated either by yourself, your healthcare provider, or your health insurance company. Guest Bios: E. James Song, M.D. is a nationally recognized dermatologist and clinical researcher who is also a Clinical Instructor at the University of Washington. Dr Song is recognized as a key opinion leader in treating psoriasis and atopic dermatitis. He is actively involved in the development of new therapies for dermatologic disease and has firsthand experience with treatments before they come to market. Dr. Song has been published extensively in peer review journals and regularly participates in meetings both as a lecturer and attendee. He is also a Medical Board member of the National Psoriasis Foundation. He believes that the best health outcomes come from shared decision making between the patient and physician. Dr. Song strives to help patients understand not only their condition, but all their treatment options. Ana Rinck is a patient advocate and volunteer for the National Psoriasis Foundation. She developed psoriasis in 2009 following symptoms she noticed for a few years which proved to be challenging to diagnose. She managed for many years on topicals and intralesional injections. In 2018 she was diagnosed with psoriatic arthritis and started use of a biologic realizing she needed to protect her joints from further damage. She now uses a biosimilar to manage her psoriatic disease. Ana owns her own private consulting business and is an Operations and Project Manager. Resources: -Learn more about biosimilars, interchangeability, and state substitution rules. -Armstrong A, Callis Duffin K, Feldman S, Glick B, Kalb R, Reddy S, Schwartzman S, Yamauchi P, Calabrese C, Cordoro K, Desai S, ...
    Show more Show less
    18 mins
  • Ep. 271 "Hope and Healing: Treating Nail Psoriasis"

    Ep. 271 "Hope and Healing: Treating Nail Psoriasis"
    Feb 17 2026
    Description: Nail psoriasis is tough to treat. Hear Rebecca, a patient who lives with nail psoriasis, and dermatologist Dr. Paul Yamauchi discuss the diagnosis, care, and treatment for this high-impact site. Join host Roy Pankey as he addresses the complexities of nail psoriasis from diagnosis to coping and the latest research and treatments with leading dermatologist, Dr. Paul Yamauchi from the Dermatology Institute and Skin Care Center and Clinical Science Institute, and Rebecca, a patient advocate with the National Psoriasis Foundation who lives with nail psoriasis. Listen as they discuss the challenges associated with living with nail psoriasis, and what can be done to help manage the disease from self-care to treatment choices – including the latest research developments. While nail psoriasis can be challenging to diagnose and treat, there are many actions that can be taken to help minimize the impact of this disease. Timestamps: (0:00) Intro to Psoriasis Uncovered & guest welcome Rebecca and dermatologist Dr. Paul Yamauchi. (0:58) Signs or changes to nails that indicate nail psoriasis is present. (2:07) Elements and challenges to diagnosing nail psoriasis. (4:41) What is a nail biopsy and how is it done. (5:25) How nail psoriasis relates to psoriatic arthritis. (6:19) What flares my nail psoriasis. (6:57) There are many treatment choices used to treat nail psoriasis based on convenience, impact of disease, preference, and when to expect improvement. (10:13) A personal perspective on medications used to treat nail psoriasis. (10:42) Research results of the latest medications used to treat nail psoriasis. (13:03) Upcoming oral agents that could be effective in treating nail psoriasis. (15:14) Self care tips, use of nail polish and artificial nails. (19:21) Nail psoriasis is challenging to treat. Be patient with yourself and your dermatologist. Key Takeaways: · Nail psoriasis presents many challenges from living and coping with the disease to diagnosis and treatment. · Medication choices for nail psoriasis are based on convenience, impact of disease, and preference for use of topicals, phototherapy, oral agents, and/or biologics. · Since nail psoriasis takes time to see improvement, it is important to be patient with yourself and your dermatologist. Guest Bios: Dermatologist Dr. Paul Yamauchi is President and Medical Director of the Dermatology Institute and Skin Care Center and Clinical Science Institute in Santa Monia, CA. Dr. Yamauchi is a leading expert in the field of psoriasis and has extensive experience treating different types of psoriasis using the latest treatments from topicals to biologics. He is also a Clinical Professor in the Division of Dermatology with David Geffen School of Medicine at UCLA. Dr. Yamauchi has conducted over 200 clinical research trials as principal investigator and is widely regarded as an outstanding clinical research investigator exploring innovative therapies, serving on advisory ...
    Show more Show less
    23 mins
No reviews yet